Outlook Therapeutics (OTLK) Stock Price
$1.56 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
0 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Outlook Therapeutics, AI stock picks, stock alerts and much more.
OTLK AI Stock Analysis
AI stock analysis for OTLK is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Outlook Therapeutics (OTLK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Outlook Therapeutics (OTLK) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Outlook Therapeutics (OTLK), currently trading at $1.56, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About OTLK
-
Outlook Therapeutics, Inc.
-
Symbol
OTLK
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
49.9M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
OTLK Alternative Data
Web Traffic
Outlook Therapeutics receives an estimated 3092 monthly visitors to outlooktherapeutics.com.
-
Web Traffic
3092
-
Change from Previous Month
35.2%
-
3 Month Change
13.3%
-
YoY Change
13.3%
News Mentions
Outlook Therapeutics was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
50%
Reddit Mentions
Outlook Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Outlook Therapeutics has 720 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.1% over the last month.
-
Twitter Followers
720
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
7%
LinkedIn Followers
10,212 are following Outlook Therapeutics on LinkedIn, up by 1.4% over the last month.
-
LinkedIn Followers
10212
-
Daily Change
0%
-
1 Month Change
1.4%
-
3 Month Change
3.3%
Job Postings
Outlook Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Outlook Therapeutics has 45 employees, up by 2.3% over the last month.
-
LinkedIn Employees
45
-
Daily Change
0%
-
1 Month Change
2.3%
-
3 Month Change
4.7%
Business Outlook
-
Business Outlook
22
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
OTLK Financials
OTLK Key Metrics
-
Total Revenue
$0
-
Net Income
$5.7M
-
Earnings per Share
$0
-
Free cash flow
-$17M
-
EBITDA
$5.7M
-
EBITDA Ratio
33.623
-
Total Assets
$28.8M
OTLK 2-year Revenue & Income
OTLK 2-year Free Cash Flow
OTLK Technicals
OTLK SMA
OTLK RSI
FAQ
What's the current price of Outlook Therapeutics (OTLK) Stock?
The price of an Outlook Therapeutics (OTLK) share is $1.56.
What's the market cap of Outlook Therapeutics?
The current market cap of Outlook Therapeutics is 49.9M.
Should I buy or sell OTLK?
Outlook Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Outlook Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Outlook Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Outlook Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Outlook Therapeutics (OTLK) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Outlook Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Outlook Therapeutics (OTLK) that investors often compare it to?
Outlook Therapeutics (OTLK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Outlook Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Outlook Therapeutics' stock price to be around $1.4 in 2026. Starting from the current price of $1.56, this represents a 10% change in price, indicating a bearish outlook for the stock.
How to buy Outlook Therapeutics (OTLK) Stock?
Outlook Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Outlook Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.